Sean Callahan

Associate Professor

University of Utah

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sean Callahan is an Associate Professor at The University of Utah in the United States. His research focuses on the intersection of pulmonary health and technology, with recent articles investigating multi-modal machine learning classifiers for idiopathic pulmonary fibrosis, the impact of vitamin E acetate on inflammation in EVALI patients, and COVID-19 therapeutic interventions. Additionally, he examines the implications of climate change on pulmonology and the socio-ethical dimensions of health data in treating lung diseases.

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (16)

Charalampos Moschopoulos

National and Kapodistrian University of Athens

GREECE

Sean Callahan

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Multi-modal machine learning classifier for idiopathic pulmonary fibrosis predicts mortality in interstitial lung diseases

Vitamin E Acetate is Associated with Select Proinflammatory Cytokines: An Analysis of a 2020-2022 Cohort of EVALI Patients

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.

Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.

Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 Months

Uncomfortable Truths About Data, Justice, and Idiopathic Pulmonary Fibrosis in the Veterans Health Administration

Climate Change for the Pulmonologist

Alveolar macrophages from EVALI patients and e-cigarette users: a story of shifting phenotype.

The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.

Prospectively Assessed Long-Term Outcomes of Patients with E-Cigarette- or Vaping-associated Lung Injury.

Collaborators (16)

Charalampos Moschopoulos

Ivor Douglas

Fedor Lurie

Kristi J Warren

Brian Locke

Carlo Bieńkowski

Timothy Hatlen

David Dillon

Kirby Mayer

Shijing Jia

Mamta Jain

Brian Tiffany

Beatriz Díaz-Pollán

J. Pedro Teixeira

Olivia Krol

Stuart Turville

Make your next move.